Transition

Transition Journal of Hematopathology (2018) 11:27 https://doi.org/10.1007/s12308-018-0324-4 EDITORIAL William R. Macon Published online: 23 May 2018 Springer-Verlag GmbH Germany, part of Springer Nature 2018 Ten years ago, the Journal of Hematopathology made its de- [2], have been among the most popular and cited papers pub- but under the leadership of its founding Editor-in-Chief (EIC), lished in the Journal. We will certainly miss these efforts on J. Han J. M. van Krieken who retired from that position at the his part. end of 2017. In his editorial in the first issue of the Journal, Han’s retirement as EIC of the Journal does not mean he is Han acknowledged that “hematopathology is a rapidly evolv- riding quietly off into the sunset. He will continue to make ing field of pathology in which changes take place all the time. substantial contributions to the fields of hematopathology and The aim of the new journal is to bring the different develop- colorectal cancer as Professor of Pathology and as Chair of the ments together in one journal, so that the practicing Centre for Oncology at Radboud University in Nijmegen, hematopathologist is able to keep up with a variety of new Netherlands. He will also provide significant leadership to development in the field” [1]. As Han’s successor as EIC of his university as Chairman of its Board of Deans and as the Journal, I fully embrace that decade-old aim and intend to Rector Magnificus of its Board of Governors. build on his successes. Han, the Journal and I thank you for all of your efforts in Under Han’s leadership, the Journal developed a strong and the establishment of the Journal of Hematopathology and wish international group of hematopathologists with varying inter- you the best in your further endeavors. ests as associate editors and among its editorial board. I am committed to following his example for having Journal lead- ership from accomplished hematopathologists whose collec- William R. Macon tive expertise will span the breadth of our integrated Editor-in-Chief morphologic- and laboratory-based subspecialty. Maintaining geographic diversity among its directors will continue to be important for the Journal in order to meet the interests of its References worldwide readership. Over the years, the Journal has published case studies, 1. van Krieken JHJM (2008) The Journal of Hematopathology: a new original research articles, and reviews. Han has been a major adventure!? J Hematop 1:1 contributor of such works to the Journal. In fact, his regular 2. van Krieken JH (2017) New developments in the pathology of ma- reviews of new developments in the pathology of malignant lignant lymphoma. A review of the literature published from lymphoma, including one appearing in the last issue of 2017 September–August 2017. J Hematop 10:117–127 * William R. Macon Macon.William@mayo.edu Mayo Clinic, Rochester, MN, USA http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Hematopathology Springer Journals

Transition

Free
1 page
Loading next page...
1 Page
 
/lp/springer_journal/transition-BJza27z22d
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2018 by Springer-Verlag GmbH Germany, part of Springer Nature
Subject
Medicine & Public Health; Pathology; Hematology
ISSN
1868-9256
eISSN
1865-5785
D.O.I.
10.1007/s12308-018-0324-4
Publisher site
See Article on Publisher Site

Abstract

Journal of Hematopathology (2018) 11:27 https://doi.org/10.1007/s12308-018-0324-4 EDITORIAL William R. Macon Published online: 23 May 2018 Springer-Verlag GmbH Germany, part of Springer Nature 2018 Ten years ago, the Journal of Hematopathology made its de- [2], have been among the most popular and cited papers pub- but under the leadership of its founding Editor-in-Chief (EIC), lished in the Journal. We will certainly miss these efforts on J. Han J. M. van Krieken who retired from that position at the his part. end of 2017. In his editorial in the first issue of the Journal, Han’s retirement as EIC of the Journal does not mean he is Han acknowledged that “hematopathology is a rapidly evolv- riding quietly off into the sunset. He will continue to make ing field of pathology in which changes take place all the time. substantial contributions to the fields of hematopathology and The aim of the new journal is to bring the different develop- colorectal cancer as Professor of Pathology and as Chair of the ments together in one journal, so that the practicing Centre for Oncology at Radboud University in Nijmegen, hematopathologist is able to keep up with a variety of new Netherlands. He will also provide significant leadership to development in the field” [1]. As Han’s successor as EIC of his university as Chairman of its Board of Deans and as the Journal, I fully embrace that decade-old aim and intend to Rector Magnificus of its Board of Governors. build on his successes. Han, the Journal and I thank you for all of your efforts in Under Han’s leadership, the Journal developed a strong and the establishment of the Journal of Hematopathology and wish international group of hematopathologists with varying inter- you the best in your further endeavors. ests as associate editors and among its editorial board. I am committed to following his example for having Journal lead- ership from accomplished hematopathologists whose collec- William R. Macon tive expertise will span the breadth of our integrated Editor-in-Chief morphologic- and laboratory-based subspecialty. Maintaining geographic diversity among its directors will continue to be important for the Journal in order to meet the interests of its References worldwide readership. Over the years, the Journal has published case studies, 1. van Krieken JHJM (2008) The Journal of Hematopathology: a new original research articles, and reviews. Han has been a major adventure!? J Hematop 1:1 contributor of such works to the Journal. In fact, his regular 2. van Krieken JH (2017) New developments in the pathology of ma- reviews of new developments in the pathology of malignant lignant lymphoma. A review of the literature published from lymphoma, including one appearing in the last issue of 2017 September–August 2017. J Hematop 10:117–127 * William R. Macon Macon.William@mayo.edu Mayo Clinic, Rochester, MN, USA

Journal

Journal of HematopathologySpringer Journals

Published: May 23, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off